Back to News
Market Impact: 0.55

Vertiv Reports Strong Third Quarter 2026 with Net Sales Growth of 61%, Organic Orders Growth over 100% and Diluted EPS Growth of 91% (Adjusted Diluted EPS Growth of 78%); Raises Full Year 2026 Guidance Across All Key Metrics

Source: PR Newswire

Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsTechnology & Innovation
Vertiv Reports Strong Third Quarter 2026 with Net Sales Growth of 61%, Organic Orders Growth over 100% and Diluted EPS Growth of 91% (Adjusted Diluted EPS Growth of 78%); Raises Full Year 2026 Guidance Across All Key Metrics

Vertiv’s Q3 2026 net sales rose 61% year over year to $4.313 billion, while adjusted operating profit increased 83% to $1.087 billion and adjusted diluted EPS rose 78% to $2.21. Adjusted operating margin expanded 290 basis points to 25.2%; organic orders grew more than 100% year over year, and the company raised full-year 2026 net sales guidance by $650 million. Updated midpoint guidance implies full-year sales of $14.65 billion and adjusted diluted EPS of $7.15, up 38% and 70%, respectively, from 2025.

Analysis

The bullish signal is less the headline growth rate than the possibility that Vertiv (VRT) is converting capacity scarcity into both share gains and operating leverage. If customers value delivery certainty over lowest bid, faster product cycles and lifecycle service can strengthen switching costs; that benefits VRT relative to competing power and cooling vendors such as Eaton and Schneider Electric. But broad demand does not establish durable share capture: customers may dual-source, and competitors’ capacity additions could restore pricing pressure over the next 6–18 months.

The key near-term check is cash conversion. Receivables and inventory expanded sharply alongside sales, while management cited working-capital drag. The full-year free-cash-flow outlook implies a materially lower fourth-quarter contribution than the third quarter, so order growth is not yet equivalent to cash realization. Treat management’s >100% organic order growth as a leading indicator, not booked revenue; verify backlog conversion, cancellations, and customer payment terms on the call. Also monitor regional mix: APAC margins remain below the company average, while EMEA’s year-to-date organic sales weakness makes its quarterly improvement worth validating.

For the next 1–3 months, guidance execution and cash conversion should matter more than another demand assertion. Over 6–18 months, capacity utilization, service attachment, and competitor supply determine whether current margins persist. The contrarian risk is that investors extrapolate an unusually strong buildout before customer projects and power availability translate into sustained deployments. Without valuation and positioning data, avoid chasing an opening gap; the thesis weakens if orders decelerate, backlog converts poorly, or free cash flow misses guidance.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

strongly positive

Sentiment Score

0.78

Ticker Sentiment

VRT0.90

Key Decisions for Investors

  • Keep VRT on a staged-long watchlist rather than buying an opening spike; use the earnings-call Q&A and subsequent trading to assess whether the market rewards cash conversion as well as growth.
  • For an existing long, retain exposure but size against execution risk. Reassess if order momentum slows, cancellations rise, or working capital continues to absorb cash despite revenue growth.
  • Track fourth-quarter adjusted free-cash-flow delivery against the full-year outlook, plus receivables, inventory, and backlog conversion in the next report; a miss would challenge the quality of demand and the margin premium.
  • Do not short Eaton or Schneider Electric solely on this release. Monitor their capacity, lead times, and data-center order commentary for evidence that VRT is taking share rather than benefiting from a market-wide cycle.

More News

From AllMind Research

Browse all research